title: The changing face of hypophosphatemic disorders in the FGF-23 era.
abstract: In the past decade, research in genetic disorders of hypophosphatemia has significantly expanded our understanding of phosphate metabolism. X-linked hypophosphatemia (XLH) is the most common inherited form of rickets due to renal phosphate wasting. Recent understanding of the mechanisms of disease and role of fibroblast growth factor 23 (FGF-23) in XLH and other hypophosphatemic disorders have opened new potential therapeutic avenues. We will discuss the current standard of treatment for XLH as well as promising future directions under study.
authors.affiliation: Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
authors.forename: Janet Y
authors.initials: JY
authors.lastname: Lee
authors.forename: Erik A
authors.initials: EA
authors.lastname: Imel
mesh_terms: D053098:Familial Hypophosphatemic Rickets / Q000235:genetics / Q000378:metabolism* / Q000628:therapy; D005260:Female; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000378:metabolism / Q000502:physiology*; D040181:Genetic Diseases, X-Linked; D006801:Humans; D007223:Infant; D010710:Phosphates / Q000378:metabolism*
chemical_list: C000717427:FGF23 protein, human; D010710:Phosphates; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23